Start for free
Start for free
Novalis Biotechnology Incubation logo

Novalis Biotechnology Incubation

Europe, Oost-Vlaanderen, Belgium, Gent

Description

Novalis Biotech Incubation is an early-stage vc fund that invests in biotechnology and life sciences related companies.

Investor Profile

Novalis Biotechnology Incubation has made 12 investments, with 1 in the past 12 months and 58% as lead.

Stage Focus

  • Seed (58%)
  • Series A (33%)
  • Debt Financing (8%)

Country Focus

  • United States (25%)
  • The Netherlands (17%)
  • France (17%)
  • Belgium (17%)
  • Switzerland (8%)
  • Germany (8%)
  • Sweden (8%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical Device
  • Artificial Intelligence (Ai)
  • Machine Learning
  • Natural Language Processing
  • Software
  • Video
  • Biopharma
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Novalis Biotechnology Incubation frequently co-invest with?

PV
Particular Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Risk and Return
Risk and Return
North America, Virginia, United States, Mclean
Co-Investments: 2
Lair East Labs
Lair East Labs
North America, New York, United States, New York
Co-Investments: 1
SH
Strathmere Healthcare Partners
North America, Texas, United States, Dallas
Co-Investments: 3
CH
Carela Holding
Europe, Hamburg, Germany, Hamburg
Co-Investments: 1
Threshold Impact
Threshold Impact
North America, Alberta, Canada, Edmonton
Co-Investments: 2
Relentless Pursuit Partners
Relentless Pursuit Partners
North America, British Columbia, Canada, Vancouver
Co-Investments: 3
Bpifrance
Bpifrance
Europe, Ile-de-France, France, Maisons-alfort
Co-Investments: 2
Alchemist Accelerator
Alchemist Accelerator
North America, California, United States, San Francisco
Co-Investments: 1
Voxel Ventures
Voxel Ventures
Europe, Hessen, Germany, Frankfurt
Co-Investments: 1

Which angels does Novalis Biotechnology Incubation often collaborate with?

Ray Muzyka
Ray Muzyka
North America, Alberta, Canada, Edmonton
Shared Deals: 1

What are some of recent deals done by Novalis Biotechnology Incubation?

Modality.AI, Inc.

San Francisco, California, United States

Self-Driven Neurological Assessments

Artificial Intelligence (AI)Health CareMachine LearningNatural Language ProcessingSoftwareVideo
SeedOct 7, 2024
Amount Raised: $570,523
Alithea Genomics

Lausanne, Vaud, Switzerland

Alithea Genomics backgrounds in bioengineering, molecular biology, genomics and lab operations reflect their complementary expertise.

BiopharmaBiotechnology
SeedMar 14, 2024
Amount Raised: $3,166,285
Altavo

Dresden, Sachsen, Germany

Altavo operates as a medical device startup.

Health CareManufacturingMedical Device
Series AFeb 20, 2024
Amount Raised: $5,404,950
Rarity Bioscience

Uppsala, Uppsala Lan, Sweden

Rarity Bioscience provides multiplex assays for detecting nucleic acid sequences in biological samples like liquid biopsies.

BiotechnologyHealth CareMedical
SeedFeb 6, 2023
Amount Raised: $536,453
Enzyre

Nijmegen, Gelderland, The Netherlands

Enzyre is a developer of diagnostic technology.

Health CareMedical Device
Series ANov 2, 2022
Amount Raised: $11,776,679
Modality.AI, Inc.

San Francisco, California, United States

Self-Driven Neurological Assessments

Artificial Intelligence (AI)Health CareMachine LearningNatural Language ProcessingSoftwareVideo
SeedOct 7, 2022
Amount Raised: $1,119,113
Carroucell

Sainte-hélène-du-lac, Rhone-Alpes, France

Carroucell is the microcarrier supplier for cell culture in bioreactor.

BiotechnologyTherapeutics
Series ASep 7, 2022
Amount Raised: $1,499,697
Trince

Asse, Vlaams-Brabant, Belgium

Trince is advancing cell-based science and therapeutics by facilitating the delivery of molecules into cells, both in vitro and ex vivo.

BiopharmaBiotechnologyGenetics
SeedDec 4, 2021
Amount Raised: $4,525,598
Modality.AI, Inc.

San Francisco, California, United States

Self-Driven Neurological Assessments

Artificial Intelligence (AI)Health CareMachine LearningNatural Language ProcessingSoftwareVideo
SeedJul 30, 2021
Amount Raised: $2,520,765
RheaVita

Zwijnaarde, Oost-Vlaanderen, Belgium

RheaVita is a pharmaceutical company developing continuous freeze-drying technology for biopharmaceutical products.

BiopharmaBiotechnologyMechanical EngineeringPharmaceutical
Series AJun 2, 2021
Amount Raised: $3,052,350
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator